The drug ent-verticilide reduced A-fib incidence and duration in an animal model, suggesting it may be a viable therapeutic option.
Smooth muscle cells that line the aorta differ in development but not in the adult, a finding that has implications for understanding aortic development and disease.
Reducing heart muscle response to calcium could decrease the risk of fatal arrhythmias after heart attacks.
Antacids that block a certain enzyme pose a risk for a common cardiac problem in premature infants.
A “profile” of the genes and regulatory networks that govern early heart valve development lay the groundwork for generating valves from a patient’s own cells.
Blocking a serotonin receptor may provide a novel therapy for heart valve disease.
Accessibility Tools